• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Oct24
Bio-S released FY2025 9 Months Earnings on October 24 After-Market (BJT), with actual revenue of CNY 509.88 M and EPS of CNY 0.0911
01:00
Bio-S released FY2025 Q3 earnings on October 24 After-Market (BJT), actual revenue CNY 177.53 M, actual EPS CNY 0.0303
01:00
Oct17
Bio-S to Release FY2025 Q3 Earnings on October 25 After-Market (BJT)
00:28
Sep24
Insilico Medicine Signs Drug Development Cooperation Agreement with BCI Pharma
13:39
Aug26
Bio-S released FY2025 Q2 earnings on August 26 After-Market (BJT), actual revenue CNY 203.63 M, actual EPS CNY 0.3008
01:00
Bio-S released FY2025 Semi-Annual earnings on August 26 After-Market BJT, actual revenue CNY 332.35 M, actual EPS CNY 0.03
01:00

Schedules & Filings

Schedules
Filings
Oct24
Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 177.53 M, Net Income 3.026 M, EPS 0.0303

Aug27
Earning Release(CST)

FY2025 Semi-Annual Earning Release

Aug26
Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 203.63 M, Net Income 29.3 M, EPS 0.3008

View More

Stock List

Top Gainers
Top Decliners
Northbound Connect
Symbol
Price
%Chg
Change
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy